Y Osada
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
- Pharmacology top 1%
- Antibiotics Pharmacokinetics and Efficacy
Papers in
-
- Cancer therapeutics and mechanisms 17
- Phenothiazines and Benzothiazines Synthesis and Activities 7
- Pharmacology 25
- Antibiotics Pharmacokinetics and Efficacy 24
- Co-authors
- T Une (18 shared papers)Kenichi Sato (8 shared papers)Noriko Tanaka (8 shared papers)I Hayakawa (6 shared papers)Kazuki Hoshino (6 shared papers)Haruko Ogawa (7 shared papers)Masayasu Sekiguchi (2 shared papers)Michio Iwahana (3 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (14 papers)Infection and Immunity (6 papers)Chemical and Pharmaceutical Bulletin (5 papers)Chemotherapy (4 papers)Cancer Immunology Immunotherapy (2 papers)
- Partner nations
- JapanSouth KoreaUnited States
In The Last Decade
Y Osada
82 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 106
- Molecular Medicine 426
- Pharmacology 655
- Microbiology 123
- Immunology and Allergy 110
- Endocrinology 99
Countries citing papers authored by Y Osada
This map shows the geographic impact of Y Osada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Osada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Osada more than expected).
Fields of papers citing papers by Y Osada
This network shows the impact of papers produced by Y Osada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Osada. The network helps show where Y Osada may publish in the future.
Co-authors
The 25 scholars most cited alongside Y Osada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1982 | 249 | |
| 2 | Inhibition of angiogenesis and tumor growth by a synthetic laminin peptide, CDPGYIGSR-NH2. | 1991 | 144 |
| 3 | 1989 | 141 | |
| 4 | 1988 | 125 | |
| 5 | 1992 | 111 | |
| 6 | 1992 | 68 | |
| 7 | 1989 | 66 | |
| 8 | 1987 | 56 | |
| 9 | 1983 | 56 | |
| 10 | Antitumor effects of an antiangiogenic polysaccharide from an Arthrobacter species with or without a steroid. | 1989 | 54 |
| 11 | 1984 | 49 | |
| 12 | 1982 | 48 | |
| 13 | 2009 | 43 | |
| 14 | 1991 | 43 | |
| 15 | 1983 | 42 | |
| 16 | 1991 | 40 | |
| 17 | 1991 | 36 | |
| 18 | 1982 | 34 | |
| 19 | 1990 | 33 | |
| 20 | 1995 | 29 |
About Y Osada
Y Osada is a scholar working on Molecular Biology, Pharmacology, Molecular Medicine, Immunology and Oncology, having authored 86 papers that have together received 2.0k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (24 papers), Antibiotic Resistance in Bacteria (22 papers), Cancer therapeutics and mechanisms (17 papers), Immune Response and Inflammation (10 papers), Phenothiazines and Benzothiazines Synthesis and Activities (7 papers), Antimicrobial Resistance in Staphylococcus (7 papers), Escherichia coli research studies (7 papers) and Neutropenia and Cancer Infections (5 papers). The work is most often cited by research in Molecular Medicine (426 citations), Pharmacology (655 citations), Microbiology (123 citations), Immunology and Allergy (110 citations) and Endocrinology (99 citations). Y Osada has collaborated with scholars based in Japan, South Korea and United States. Frequent co-authors include T Une, Kenichi Sato, Noriko Tanaka, I Hayakawa, Kazuki Hoshino, Haruko Ogawa, Masayasu Sekiguchi, Michio Iwahana, Manabu Inoue and Yoshiharu Matsuura. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Infection and Immunity, Chemical and Pharmaceutical Bulletin, Chemotherapy and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.